Vo JB, Ramin C, Veiga LHS, Brandt C, et al. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in U.S. breast cancer survivors. J Natl Cancer Inst 2024 May 8:djae107. doi: 10.1093.
PMID: 38718210